In the training set, the low expression of BCL2, DAPK2, CASP1, CASP3, HDAC1, PRKAB1, MTMR14, BID, BIRC5, and MYC was more beneficial to the survival of CRC patients, as well as the high expression of ULK3, CAPN2, DAPK1, RAF1, and BAG3 corresponded to longer survival (Figure 3J). Here, BID is linked to colorectal carcinoma.